Medical Group Expects FTC Action on Transgender Procedures for Minors
Do No Harm, a medical group, has submitted comments to the Federal Trade Commission (FTC) disputing the safety and effectiveness of gender-affirming care for minors, including its claimed ability to "reduce the risk of suicide."
Do No Harm told FTC it disputes that gender-affirming care for minors is safe, effective, and "reduces the risk of suicide."
According to Dr. Kurt Miceli, medical director of Do No Harm, the group expects the FTC to take action to protect children from "unsafe and unproven sex change interventions" and seek justice for those already harmed.
- Do No Harm submitted comments to the FTC's public inquiry on the child transgender industry.
- The group anticipates the FTC will take meaningful action to protect vulnerable children.
Author's summary: Medical group seeks FTC action to protect minors from transgender procedures.